Retirement of Guidelines

Retirement of Guidelines: 

Day GS, Scarmeas N, Dubinsky R, Coerver K, Mostacero A, West B, Wessels SR, Armstrong MJ. Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: A Report of the AAN Guidelines Subcommittee. Neurology. 2022 Apr 12;98(15):619-631. doi: 10.1212/WNL.0000000000200176.